After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Art Garfunkel discusses his experience living with psoriasis as part of Sun Pharma’s I LUV YA for The Long Haul campaign.

Welcome to the Sun Pharma Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ahead of the market with our in-depth coverage of Sun Pharma, including ...

Sun Pharmaceutical Industries Ltd. 524715 shares rallied 1.04% to 1,705.15 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE SENSEX ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Sun Pharmaceuticals is one of India’s largest pharmaceutical companies with over 8% share in the domestic market. It owns 35 ...

Sun Pharmaceutical Industries, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1652. The stock has experienced fluctuations ...

The pharma sector is likely to maintain steady earnings. Most brokerages flag US business recovery as the key swing factor ...